Coverage dated October 13, 2023 to October 18, 2023
Pfizer more than doubles price of lifesaving Covid-19 medication Paxlovid as US transitions out of pandemic phase
Headline from KTVZ Bend
By Meg Tirrell, CNN (CNN) — The price of the lifesaving Covid-19 antiviral medication Paxlovid will more than double as the United States transitions out of the emergency phase of the pandemic, drugmaker Pfizer said Wednesday.
KTVZ Bend's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
By Meg Tirrell, CNN (CNN) — The price of the lifesaving Covid-19 medication Paxlovid is likely to rise next year for most patients as the United States continues to transition out of the emergency phase of the pandemic, sparking concerns among doctors that it will become less accessible.
The drugmaker, which has begun negotiating with pharmacy-benefit managers and health plans this week, is expected to offer steep discounts to ensure wide access.
Pfizer Inc. will sell its Covid pill Paxlovid to private payers in the US at a list price of $1390 for a 5-day course, more than twice what it charged the government for the antiviral during the pandemic.
By Meg Tirrell, CNN (CNN) — The price of the lifesaving Covid-19 antiviral medication Paxlovid will more than double as the United States transitions out of the emergency phase of the pandemic, drugmaker Pfizer said Wednesday.
The price of the lifesaving COVID-19 antiviral medication Paxlovid will more than double as the United States transitions out of the emergency phase of the pandemic.
(CNN) — The price of the lifesaving Covid-19 antiviral medication Paxlovid will more than double as the United States transitions out of the emergency phase of
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Pfizer more than doubles price of lifesaving Covid-19 medication Paxlovid as US transitions out of pandemic phase | Since Then
